BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29058705)

  • 21. Metastasis suppressor NM23 limits oxidative stress in mammals by preventing activation of stress-activated protein kinases/JNKs through its nucleoside diphosphate kinase activity.
    Peuchant E; Bats ML; Moranvillier I; Lepoivre M; Guitton J; Wendum D; Lacombe ML; Moreau-Gaudry F; Boissan M; Dabernat S
    FASEB J; 2017 Apr; 31(4):1531-1546. PubMed ID: 28077425
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeting tumor metastasis by regulating Nm23 gene expression.
    Prabhu VV; Siddikuzzaman ; Grace VM; Guruvayoorappan C
    Asian Pac J Cancer Prev; 2012; 13(8):3539-48. PubMed ID: 23098432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival.
    Qu S; Long J; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
    Clin Cancer Res; 2008 Aug; 14(15):4787-93. PubMed ID: 18676749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamin controls extracellular level of Awd/Nme1 metastasis suppressor protein.
    Romani P; Papi A; Ignesti M; Soccolini G; Hsu T; Gargiulo G; Spisni E; Cavaliere V
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Nov; 389(11):1171-1182. PubMed ID: 27449069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.
    Tan CY; Chang CL
    Lab Invest; 2018 Feb; 98(2):219-227. PubMed ID: 28991262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-139-5p negatively regulates NME1 expression in hepatocellular carcinoma cells.
    Yang J; Li Z; Pang Y; Zhou T; Sun J; Cheng XY; Zheng WV
    Adv Clin Exp Med; 2022 Jun; 31(6):655-670. PubMed ID: 35438846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials.
    Hamby CV; Mendola CE; Potla L; Stafford G; Backer JM
    Biochem Biophys Res Commun; 1995 Jun; 211(2):579-85. PubMed ID: 7794272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of metastasis suppressor NME1 by a key metabolic cofactor coenzyme A.
    Yu BYK; Tossounian MA; Hristov SD; Lawrence R; Arora P; Tsuchiya Y; Peak-Chew SY; Filonenko V; Oxenford S; Angell R; Gouge J; Skehel M; Gout I
    Redox Biol; 2021 Aug; 44():101978. PubMed ID: 33903070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis.
    Adam K; Lesperance J; Hunter T; Zage PE
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392889
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Felix I; Lomada SK; Barth H; Wieland T
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [NM23, an example of a metastasis suppressor gene].
    Boissan M; Lacombe ML
    Bull Cancer; 2012 Apr; 99(4):431-40. PubMed ID: 22429909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Metastasis Suppressor Protein Nme1 Is a Concentration-Dependent Modulator of Ca
    Royer L; Shangraw K; Herzog JJ; Pouvreau S; Marr MT; Paradis S
    Biochemistry; 2019 Jun; 58(24):2710-2714. PubMed ID: 31141673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer.
    Fiore LS; Ganguly SS; Sledziona J; Cibull ML; Wang C; Richards DL; Neltner JM; Beach C; McCorkle JR; Kaetzel DM; Plattner R
    Oncogene; 2014 Sep; 33(36):4508-4520. PubMed ID: 24096484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential contributions of antimutator activity to the metastasis suppressor function of NM23-H1.
    Kaetzel DM; McCorkle JR; Novak M; Yang M; Jarrett SG
    Mol Cell Biochem; 2009 Sep; 329(1-2):161-5. PubMed ID: 19381784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of non-metastatic 2 (NME2)-mediated control of metastasis across tumor types.
    Thakur RK; Yadav VK; Kumar P; Chowdhury S
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Oct; 384(4-5):397-406. PubMed ID: 21556888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastasis suppressor genes in clinical practice: are they druggable?
    Gelman IH
    Cancer Metastasis Rev; 2023 Dec; 42(4):1169-1188. PubMed ID: 37749308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleoside diphosphate kinase Nm23-M1 involves in oligodendroglial versus neuronal cell fate decision in vitro.
    Owlanj H; Jie Yang H; Wei Feng Z
    Differentiation; 2012 Nov; 84(4):281-93. PubMed ID: 23023023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of NME1 (NM23-H1) in Patients with Digestive System Neoplasms: A Systematic Review and Meta-Analysis.
    Han W; Shi CT; Cao FY; Cao F; Chen MB; Lu RZ; Wang HB; Yu M; He DW; Wang QH; Wang JF; Xu XX; Ding HZ
    PLoS One; 2016; 11(8):e0160547. PubMed ID: 27518571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.
    Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM
    Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression levels of CSNK1A1 and AAC-11, but not NME1, in tumor tissues as prognostic factors in NSCLC patients.
    Wang Z; Liu H; Liu B; Ma W; Xue X; Chen J; Zhou Q
    Med Sci Monit; 2010 Aug; 16(8):CR357-64. PubMed ID: 20671611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.